Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins
- PMID: 7453783
- DOI: 10.1056/NEJM198102263040901
Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins
Abstract
We observed complement activation in 15 adults undergoing total cardiopulmonary bypass. Plasma levels of C3a were significantly elevated (P < 0.0001) at the beginning of the procedure, and they continued to increase steadily thereafter. At the end of the procedure, C3a levels were more than five times higher than preoperative levels. Plasma levels of C5a (a factor that binds avidly to neutrophils) did not change significantly during cardiopulmonary bypass. Instead, there was significant neutrophilia (P = 0.03) during bypass, and significant transpulmonary neutropenia (P = 0.0002) occurred when cardiopulmonary circulation was reestablished at partial bypass. The neutropenia is consistent with pulmonary-vascular sequestration of C5a-activated granulocytes. We also found that incubation of blood with the nylon-mesh liner of bubble oxygenators, as well as vigorous oxygenation of whole blood, promotes conversion of complement. We conclude that the complement-derived inflammatory mediators C3a and C5a produced during extracorporeal circulation may contribute to the pathogenesis of "post-pump syndromes."
Similar articles
-
Complement activation and neutropenia occurring during cardiopulmonary bypass.J Thorac Cardiovasc Surg. 1981 Mar;81(3):370-7. J Thorac Cardiovasc Surg. 1981. PMID: 6970304
-
[Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].Kardiol Pol. 1992;36(2):67-72. Kardiol Pol. 1992. PMID: 1583828 Polish.
-
Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.J Thorac Cardiovasc Surg. 1986 Feb;91(2):252-8. J Thorac Cardiovasc Surg. 1986. PMID: 3511328 Clinical Trial.
-
Complement split products and the pathogenesis of SLE.Hosp Pract (Off Ed). 1988 Dec 15;23(12):45-56. doi: 10.1080/21548331.1988.11703590. Hosp Pract (Off Ed). 1988. PMID: 3142905 Review. No abstract available.
-
[Complement activation and inflammation].Rinsho Byori. 2006 Jul;54(7):744-56. Rinsho Byori. 2006. PMID: 16913666 Review. Japanese.
Cited by
-
Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.Gen Thorac Cardiovasc Surg. 2013 Sep;61(9):485-96. doi: 10.1007/s11748-013-0279-4. Epub 2013 Jul 23. Gen Thorac Cardiovasc Surg. 2013. PMID: 23877427
-
Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.Infect Immun. 1987 Aug;55(8):1867-72. doi: 10.1128/iai.55.8.1867-1872.1987. Infect Immun. 1987. PMID: 2440808 Free PMC article.
-
Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.Intensive Care Med. 1987;13(2):89-95. doi: 10.1007/BF00254791. Intensive Care Med. 1987. PMID: 3553271 Review. No abstract available.
-
Pathophysiology and pathogenesis of post-resuscitation myocardial stunning.Heart Fail Rev. 2012 Jan;17(1):117-28. doi: 10.1007/s10741-011-9255-1. Heart Fail Rev. 2012. PMID: 21584712 Review.
-
Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs.Can Anaesth Soc J. 1984 Sep;31(5):534-40. doi: 10.1007/BF03009539. Can Anaesth Soc J. 1984. PMID: 6333913
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical